SCHEMBL30368541

SCHEMBL30368541

CC(C)Nc1c([N+](=O)[O-])cnc2c1c(I)c(Cl)n2COCC[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26083491 1.00
SCHEMBL24469108 0.88 PIN1 (0.30)
SCHEMBL26083489 0.81 MAPT (0.32)
SCHEMBL30368338 0.81 MAPT (0.32)
SCHEMBL30493660 0.76
SCHEMBL26083471 0.75 NPC1 (0.31)
SCHEMBL29809732 0.75 ATR (0.34)
SCHEMBL26083492 0.75 ATR (0.34)
SCHEMBL26326384 0.73 NPC1 (0.33)
SCHEMBL30368183 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116323612-A Tricyclic urea compounds as JAK 2V 617F inhibitors 因赛特公司 2023-06-23 CN disclosed
EP-4175719-A1 TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS Incyte Corporation (US) 2023-05-10 EP disclosed